A multicenter, randomized, open label, two formulation, crossover bioequivalence trial of doxorubicin hydrochloride liposomal injection in Chinese patients with metastatic breast cancer

A multicenter, randomized, open label, two formulation, crossover bioequivalence trial of doxorubicin hydrochloride liposomal injection in Chinese patients with metastatic breast cancer

Abstract Purpose The primary objectives of this trial were aimed at exploring the pharmacokinetic profiles and the human bioequivalence of an intravenous liposomal injection of doxorubicin hydrochloride in comparison with a reference formulation in Chinese patients diagnosed with metastatic breast c...

Full description

Saved in:

Bibliographic Details
Main Authors:	Jingshu Wang, Xiuping Lai, Herui Yao, Hui Yang, Xiaolong Cao, Xiaochen Wang, Ying Wang, Weiqi Nian, Xiaodong Zheng, Qingxiu Mai, Anding Liu, Xiaozhi Lv, Xiaoying Bi, Junyi Chen, Junyan Wu, Suiwen Ye
Format:	Article
Language:	English
Published:	Springer 2025-01-01
Series:	Journal of Cancer Research and Clinical Oncology
Subjects:	Breast cancer Doxorubicin hydrochloride liposomes Pharmacokinetics Safety Bioequivalence test
Online Access:	https://doi.org/10.1007/s00432-025-06086-0
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Characterization and in vitro anticancer study of PEGylated liposome dually loaded with ferulic acid and doxorubicin
by: Andang Miatmoko, et al.
Published: (2025-01-01)

The role of size in PEGylated liposomal doxorubicin biodistribution and anti‐tumour activity
by: Saba Dadpour, et al.
Published: (2022-09-01)

Comparative study on the bioavailability and bioequivalence of rifapentine capsules in humans
by: Ying Qi, et al.
Published: (2025-01-01)

Pimobendan oral solution is bioequivalent to pimobendan chewable tablets in beagle dogs
by: Olaf Kuhlmann, et al.
Published: (2025-01-01)

Pharmacokinetics and Bioequivalence of Two Fixed-Dose Combination Tablets of Valsartan/Amlodipine (80/5 Mg) in Healthy Chinese Subjects
by: Tian M, et al.
Published: (2025-01-01)

Bioequivalence study of fluticasone propionate nebuliser suspensions in healthy Chinese subjects
by: Feng Cheng, et al.
Published: (2025-01-01)

Evaluating the pharmacokinetics and safety of blonanserin tablets and Lonasen®: a randomized, open-label, two-period, two-sequence, self-crossover phase I clinical trial
by: Bo Qiu, et al.
Published: (2025-01-01)

Investigation of the efficacy of tyrosol on doxorubicin-induced acute cardiotoxicity in rats
by: Mustafa Cellat, et al.
Published: (2022-09-01)

Effect of pimobendan on cytokine levels in doxorubicin-induced cardiotoxicity
by: Burak Dik, et al.

Doxorubicin-loaded PEGylated liposome modified with ANGPT2-specific peptide for integrative glioma-targeted imaging and therapy
by: Hongyan Li, et al.
Published: (2025-02-01)

Streptomyces-derived nano-doxorubicin: Clinical status and patents granted
by: Kaur Prabhjot, et al.
Published: (2024-01-01)

Analysis of doxorubicin and fullerenol in rat serum by micellar electrokinetic capillary chromatography
by: Injac Rade, et al.
Published: (2024-09-01)

Histopathological evaluation of the effects of thymoquinone and resveratrol on the liver in rats administered doxorubicin
by: Mehmet Burak Ates, et al.
Published: (2022-09-01)

Cannabidiol Ameliorates Doxorubicin-Induced Myocardial Injury via Activating Hippo Pathway
by: Dong T, et al.
Published: (2025-01-01)

Determination of protective effectiveness of nerium oleander distillation in doxorubicin-induced organ damages
by: Burak Dik, et al.

The potential synergistic effect of combining doxorubicin with vorinostat in urothelial carcinoma therapy
by: Cheng-Huang Shen, et al.
Published: (2025-01-01)

Apelinergic System Affects Electrocardiographic Abnormalities Induced by Doxorubicin
by: Kasper Buczma, et al.
Published: (2025-01-01)

Survival Analysis of Ovarian Carcinosarcomas Depending on Platinum or Doxorubicin Based Adjuvant Chemotherapy
by: İlker Selçuk, et al.
Published: (2015-04-01)

Investigation of Doxorubicin Efficiency in Some Hematological Parameters in Women with Breast Cancer in Iraq
by: Hanan B. Saadon
Published: (2024-12-01)

Enhancing Anticancer Potential: Investigating the Synergistic Impact of Doxorubicin and Curcumin on HeLa and Vero Cells in Vitro
by: Windy Aristiani, et al.
Published: (2024-04-01)

Ecofriendly spectrophotometric methods for simultaneous determination of remdesivir and moxifloxacin hydrochloride as co administered drugs in corona virus treatment
by: Eman A. Madbouly, et al.
Published: (2025-01-01)

Investigation of Kidney Histopathology in Rats Receiving Methamphetamine Simultaneously with Berberine Hydrochloride and Aerobic Exercise
by: Danial Naghipour, et al.
Published: (2025-01-01)

Evaluation of Five Ready-to-Use Bases for the Topical Administration of Propranolol Hydrochloride to Treat Infantile Hemangioma
by: Chiara Lacassia, et al.
Published: (2025-01-01)

Liposomal Formulation of Hydroxychloroquine Can Inhibit Autophagy In Vivo
by: Wieslawa H. Dragowska, et al.
Published: (2024-12-01)

Effect of selected catechins on doxorubicin antiproliferative efficacy and hepatotoxicity in vitro
by: Rudolfová Petra, et al.
Published: (2014-06-01)

Preparation, characterization, and in vivo pharmacokinetics of thermosensitive in situ nasal gel of donepezil hydrochloride
by: Gu Fugen, et al.
Published: (2020-09-01)

Application of a liposomal subunit vaccine in chickens for reduction of Campylobacter gut colonisation
by: Łasica Anna, et al.
Published: (2024-11-01)

Peiminine Enhances Doxorubicin Cytotoxicity and Downregulates hsa-miR-106a-5p and hsa -miR-181a-5p in Human Gastric Adenocarcinoma Cells
by: Shirin Hedayati, et al.
Published: (2024-12-01)

Astaxanthin mitigates doxorubicin-induced cardiotoxicity via inhibiting ferroptosis and autophagy: a study based on bioinformatic analysis and in vivo/vitro experiments
by: Bowen Yin, et al.
Published: (2025-01-01)

Are We Ready to Measure Skin Permeation of Modern Antiaging GHK–Cu Tripeptide Encapsulated in Liposomes?
by: Karolina Ogórek, et al.
Published: (2025-01-01)

Doxorubicin-Conjugated Nanoparticles for Potential Use as Drug Delivery Systems
by: Alua Imantay, et al.
Published: (2025-01-01)

Anionic liposomes prepared without organic solvents for effective siRNA delivery
by: Xiu Han, et al.
Published: (2023-05-01)

Enhancing in Vitro anti-metastatic efficacy and deep penetration into tumor spheroid of docetaxel-loaded liposomes via size optimization for prostate cancer treatment
by: Saksorn Klibaim, et al.
Published: (2025-03-01)

Molecular imprinted polymer-based potentiometric approach for the determination of carvedilol and ivabradine hydrochloride in dosage form, spiked human plasma and in presence of their oxidative degradates
by: Nermine V. Fares, et al.
Published: (2025-02-01)

Preparation, Modification, Characterization and Antioxidant Activities of Apigenin Liposomes
by: Siyu DAI, et al.
Published: (2025-01-01)

MEKANISME KO-KEMOTERAPI EKSTRAK ROSELLA (Hibiscus sabdariffa. L) DENGAN DOXORUBICIN PADA SEL KANKER SERVIKS (HeLa) SECARA IN VITRO
by: Intan Daud, et al.
Published: (2024-11-01)

Effectiveness of a Novel Liposomal Methylglyoxal–Tobramycin Formulation in Reducing Biofilm Formation and Bacterial Adhesion
by: Wed Alluhaim, et al.
Published: (2024-12-01)

Liposome-like encapsulation of fish oil-based self-nano emulsifying formulation for improved bioavailability
by: Iqbal Ahmad, et al.
Published: (2025-06-01)

Exploring the effects of cannabidiol encapsulation in liposomes on their physicochemical properties and biocompatibility
by: Inga Jurgelane, et al.
Published: (2025-12-01)

A state-of-the-art review of the recent advances of theranostic liposome hybrid nanoparticles in cancer treatment and diagnosis
by: Hannaneh Azimizonuzi, et al.
Published: (2025-01-01)